Surgeons who also conduct important biomedical research are struggling to obtain research funding, and that “broken pipeline” could spell extinction for surgeon-scientists and slow innovations for patients if something isn’t done, a team of UVA Health experts warns.
Cantourage Group SE (von NuWays AG) – Biotech Investments
Original-Research: Cantourage Group SE – from NuWays AG 06.12.2024 / 09:00 CET/CESTDissemination of a Research, transmitted by EQS News – a service of EQS Group